EFEarnings Feed

O

Company dossier

ONYX PHARMACEUTICALS INC

CIK 0001012140SIC 2836Biological Products, (No Diagnostic Substances)

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

6 items

10-QAccepted Nov 14, 7:00 PM ETAcc 0000912057-99-005914
ONYX PHARMACEUTICALS INC72.2 KB
ONYX PHARMACEUTICALS INC 10-Q
View filing
10-QAccepted Aug 15, 8:00 PM ETAcc 0001047469-99-032347
ONYX PHARMACEUTICALS INC41.3 KB
ONYX PHARMACEUTICALS INC 10-Q
View filing
10-QAccepted May 16, 8:00 PM ETAcc 0001047469-99-021135
ONYX PHARMACEUTICALS INC60.2 KB
ONYX PHARMACEUTICALS INC 10-Q
View filing
10-KAccepted Mar 30, 7:00 PM ETAcc 0001047469-99-012801
ONYX PHARMACEUTICALS INC252.7 KB
ONYX PHARMACEUTICALS INC 10-K
View filing
10-QAccepted Nov 12, 7:00 PM ETAcc 0001047469-98-040805
ONYX PHARMACEUTICALS INC37.4 KB
ONYX PHARMACEUTICALS INC 10-Q
View filing
10-QAccepted Aug 13, 8:00 PM ETAcc 0001047469-98-031532
ONYX PHARMACEUTICALS INC36.2 KB
ONYX PHARMACEUTICALS INC 10-Q
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
249 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA, 94080
mailing
249 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA, 94080